NCT02261597

Brief Summary

The main purpose of this study is to understand how insomnia (compared to good sleep) may affect the response of the body to a repeated physiological challenge, such as inserting the hand in ice-cold water for several times in a row. In particular, the investigators are interested in the response of markers that can be associated with stress, such as blood pressure and stress hormones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 10, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 17, 2019

Completed
Last Updated

July 22, 2019

Status Verified

July 1, 2019

Enrollment Period

2.4 years

First QC Date

October 7, 2014

Results QC Date

May 3, 2018

Last Update Submit

July 18, 2019

Conditions

Keywords

insomnia, inflammation, stress

Outcome Measures

Primary Outcomes (2)

  • Inflammatory Response to Physiological Challenge- Change in Plasma Levels of IL-6

    Inflammatory marker: Change in plasma levels of IL-6 (pg/mL).

    Baseline blood was obtained between 11am-12pm and prior to any Cold Pressor Tests (CPTs). Three CPTs were performed, with 1.5 hours between each one. The first CPT was done at 1pm. Blood draws were obtained 20min and 50 min after each CPT.

  • Stress Reactivity to Physiological Challenge- Change in Serum Levels of Cortisol

    HPA marker: Change in serum cortisol levels (ug/dL)

    Baseline blood was obtained between 11am-12pm and prior to any Cold Pressor Tests (CPTs). Three CPTs were performed, with 1.5 hours between each one. The first CPT was done at 1pm. Blood draws were obtained 20min and 50 min after each CPT.

Secondary Outcomes (1)

  • Glucocorticoid Sensitivity- Percentage of IL-6 Positive Monocytes

    Monocytes are only obtained from the baseline blood draw, which occurs at 11am.

Study Arms (2)

Insomnia Disorder

Testing reactivity of stress-related systems to repeated exposure to the cold pressor test (hand immersion into ice-cold water) among participants with a clinical diagnosis of insomnia disorder.

Behavioral: Cold Pressor Test

Healthy Control

Testing reactivity of stress-related systems to repeated exposure to the cold pressor test (hand immersion into ice-cold water) among healthy participants without a diagnosis of insomnia disorder.

Behavioral: Cold Pressor Test

Interventions

Repeated immersion of hand in ice-cold water

Healthy ControlInsomnia Disorder

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

* Individuals suffering from insomnia disorder * Healthy control sleepers

You may qualify if:

  • Women and men between the ages 18-55 years
  • Blood chemistry in the normal range
  • BMI less than or equal to 35
  • Specific to insomnia group:
  • Diagnosis of insomnia disorder based on DSM-V criteria
  • Specific for control group:
  • Good quality and quantity sleep

You may not qualify if:

  • Active infection/disease.
  • History of neurological, chronic pain, immune, cardiovascular, liver/kidney, or metabolic disorder
  • History of psychiatric disorders within the last 6 months prior to study start
  • Sleep disorders other than insomnia
  • Reynaud's disease
  • Psychotropic, sleep, or any other medications or herbs interfering with the inflammatory, autonomic, or HPA system in the last 2 weeks prior to study start, except oral contraceptives
  • In psychotherapy or any other behavioral interventions at study start
  • Donation of blood or platelets within 3 months of hospital visits
  • Pregnant/nursing.
  • Substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BIDMC

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersInflammation

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Monika Haack
Organization
Beth Israel Deaconess Medical Center, Harvard Medical School

Study Officials

  • Haack Monika, PhD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Neurology HMS

Study Record Dates

First Submitted

October 7, 2014

First Posted

October 10, 2014

Study Start

January 1, 2015

Primary Completion

June 1, 2017

Study Completion

March 1, 2018

Last Updated

July 22, 2019

Results First Posted

June 17, 2019

Record last verified: 2019-07

Locations